MTIP
SRDX

Magee Thomson Investment Partners’s Surmodics SRDX Stock Holding History

Magee Thomson Investment Partners’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-5,344
Closed -$106K – 150
2013
Q2 		$106K Buy
+5,344
New +$134K 0.02% 81

Other funds holding SRDX

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Magee Thomson Investment Partners's SRDX Position: Q3 2013 in Review

Magee Thomson Investment Partners sold out of Surmodics (SRDX) in Q3 2013, closing a stake of 5,344 shares — an estimated $106K sold.

Magee Thomson Investment Partners first reported a position in SRDX in Q2 2013 and held it in 1 quarter. The position peaked at $106K in Q2 2013. 114 funds tracked by Wall St. Rank hold SRDX as of Q3 2013.

  • Magee Thomson Investment Partners reported no remaining Surmodics position as of Q3 2013 after selling out during the quarter.
  • Magee Thomson Investment Partners sold 5,344 Surmodics shares in Q3 2013, an estimated $106K.
  • Magee Thomson Investment Partners first reported a position in Surmodics in Q2 2013 and held it in 1 quarter.
  • Magee Thomson Investment Partners's Surmodics position peaked at $106K in Q2 2013.
  • 114 funds tracked by Wall St. Rank held Surmodics as of Q3 2013.

Based on Magee Thomson Investment Partners's 13F filing for Q3 2013, filed 6 Nov 2013.